4SC provides Q3 highlights and financial forecast
4SC AG (4SC or "the Company") (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients sufferin…
4SC AG (4SC or "the Company") (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients sufferin…
The European Medicines Agency (EMA) has granted Orphan Drug Designation for resminostat for treatment of cutaneous T…
Maxell has developed a high-capacity battery that has twice the capacity*2 of the current Air Patch battery II. This ser…
Analog Microelectronics GmbH, Mainz, is adding further models with pressure ranges up to 2 bar to its high-precision AMS…
Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, today…
Wissenschaftlerinnen und Wissenschaftler vom Deutschen Krebsforschungszentrum (DKFZ) und vom Cambridge Stem Cell Instit…
Positive topline data for resminostat in RESMAIN pivotal study demonstrating 97.6% improvement in progression free survi…
The human skin is something we tend not to give much thought to, but even superficial studies shows it to be a complex a…
Innovative technologies for minimally invasive surgery and more: KUKA and Siemens Healthineers are expanding their long-…
4SC AG (4SC, FSE Prime Standard: VSC) announced that the results from the RESMAIN Study evaluating resminostat (Kinselby…